ChromaDex Corporation (CDXC) Stock Grade

About ChromaDex Corporation's fundamentals

ChromaDex Corporation is a small-cap biotechnology company with a market capitalization of $486.2 million and a P/E ratio of 28.0, indicating investors are paying a significant premium relative to current earnings. The company is currently unprofitable with a net margin of 0.0% and experienced a -100.0% year-over-year revenue decline, suggesting a major contraction in its business operations. Despite these challenges, the company generated a return on equity of 22.7%, which reflects how efficiently it deployed shareholder capital on the assets that remain. The company does not pay a dividend, and any returns would depend on potential future profitability or capital appreciation.